Today, bringing a new cancer drug to market takes an average of 10.5 years, costs more than $2.5 billion, and succeeds only 8% of the time. BostonGene is changing that reality.

Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery By Stephen Nellis June 18, 20255:05 AM PDTUpdated June 18, 2025 ...

Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. But with quantum computing, that's all changing.

AbbVie, J&J to add proprietary data to AI protein model in bid to accelerate drug discovery OpenFold3 will access the companies’ data using federation technology from Apheris Adobe By Brittany Trang ...

Meanwhile, the accuracy of leading AI systems for drug discovery, like Google DeepMind’s AlphaFold 3, tends to vary widely. Still, big pharma — and investors — appear to be enthusiastic ...

Discover LumiSTAR, a Taiwan biotech leader combining iPSC technology and patented bioimaging (LumiRDT) to revolutionize drug discovery and cell therapy platforms.

New drug discovery is a critical step for improving patients' lives. First, researchers must identify molecules in the body's cells that help drive disease, as these are potential targets for new ...

Google Deepmind has unveiled the third major version of its "AlphaFold" artificial intelligence model, designed to help scientists design drugs and target disease more effectively.